| scholarly article | Q13442814 |
| P50 | author | Martin J Green | Q41446933 |
| Peter Down | Q57514837 | ||
| P2093 | author name string | A J Bradley | |
| J E Breen | |||
| P2860 | cites work | Treatment practices and quantification of antimicrobial drug usage in conventional and organic dairy farms in Wisconsin | Q79445587 |
| Efficacy of two antibiotic treatments in curing clinical and subclinical mastitis in lactating dairy cows | Q80400309 | ||
| Costs of mastitis: facts and perception | Q80563963 | ||
| Effect of pathogen-specific clinical mastitis on milk yield in dairy cows | Q80586226 | ||
| The selective treatment of clinical mastitis based on on-farm culture results: I. Effects on antibiotic use, milk withholding time, and short-term clinical and bacteriological outcomes | Q84796261 | ||
| The selective treatment of clinical mastitis based on on-farm culture results: II. Effects on lactation performance, including clinical mastitis recurrence, somatic cell count, milk production, and cow survival | Q84796264 | ||
| Modelling in economic evaluation: an unavoidable fact of life | Q28243908 | ||
| Bayesian statistics in medical research: an intuitive alternative to conventional data analysis | Q30610858 | ||
| Cross-sectional prospective survey to study indication-based usage of antimicrobials in animals: results of use in cattle | Q33328116 | ||
| Antimicrobial use in Swiss dairy farms: quantification and evaluation of data quality | Q33551687 | ||
| Using simulation to interpret a discrete time survival model in a complex biological system: fertility and lameness in dairy cows | Q34015387 | ||
| Bayesian methods for evidence synthesis in cost-effectiveness analysis | Q36381197 | ||
| Factors affecting cure when treating bovine clinical mastitis with cephalosporin-based intramammary preparations. | Q37174318 | ||
| Quarter and cow risk factors associated with the occurrence of clinical mastitis in dairy cows in the United Kingdom | Q37213732 | ||
| Cost-effectiveness analysis: adding value to assessment of animal health welfare and production. | Q38392024 | ||
| Dairy herd mastitis and reproduction: using simulation to aid interpretation of results from discrete time survival analysis. | Q41446877 | ||
| Effects of repeated gram-positive and gram-negative clinical mastitis episodes on milk yield loss in Holstein dairy cows | Q43991537 | ||
| Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease | Q44084354 | ||
| Aetiology of clinical mastitis in six Somerset dairy herds | Q44268714 | ||
| Clinical and bacteriological response to treatment of clinical mastitis with one of three intramammary antibiotics | Q44383605 | ||
| Decision tree analysis of treatment strategies for mild and moderate cases of clinical mastitis occurring in early lactation | Q44782454 | ||
| Comparison of treatment of mastitis by oxytocin or antibiotics following detection according to changes in milk electrical conductivity prior to visible signs | Q44818757 | ||
| Bioeconomic modeling of lactational antimicrobial treatment of new bovine subclinical intramammary infections caused by contagious pathogens. | Q44847644 | ||
| Efficacy of extended pirlimycin therapy for treatment of experimentally induced Streptococcus uberis intramammary infections in lactating dairy cattle | Q44891492 | ||
| Rate of transmission: a major determinant of the cost of clinical mastitis. | Q44933262 | ||
| Comparative efficacy of local and systemic antibiotic treatment in lactating cows with clinical mastitis | Q45182965 | ||
| Living with p values: resurrecting a Bayesian perspective on frequentist statistics | Q46469093 | ||
| A comparative efficacy trial between cefuroxime and cloxacillin as intramammary treatments for clinical mastitis in lactating cows on commercial dairy farms | Q46609466 | ||
| Intramammary treatment of clinical mastitis of dairy cows with a combination of lincomycin and neomycin, or penicillin and dihydrostreptomycin | Q46609474 | ||
| Survey of the incidence and aetiology of mastitis on dairy farms in England and Wales | Q47807160 | ||
| Yield losses associated with clinical mastitis occurring in different weeks of lactation. | Q50698951 | ||
| Probabilistic sensitivity analysis: be a Bayesian. | Q51799724 | ||
| A Bayesian approach to analysing the cost-effectiveness of two primary care interventions aimed at improving attendance for breast screening. | Q51956636 | ||
| Cow-specific treatment of clinical mastitis: an economic approach. | Q54373527 | ||
| Effects of Repeated Episodes of Generic Clinical Mastitis on Mortality and Culling in Dairy Cows | Q59277215 | ||
| A Partial Budget Model to Estimate Economic Benefits of Lactational Treatment of Subclinical Staphylococcus aureus Mastitis | Q60714255 | ||
| Use of partial budgeting to determine the economic benefits of antibiotic treatment of chronic subclinical mastitis caused by Streptococcus uberis or Streptococcus dysgalactiae | Q60714272 | ||
| Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra | Q61856226 | ||
| Factors associated with cure after therapy of clinical mastitis caused by Staphylococcus aureus | Q73543286 | ||
| Recurrent clinical mastitis caused by Escherichia coli in dairy cows | Q74448827 | ||
| P304 | page(s) | 91-99 | |
| P577 | publication date | 2017-07-10 | |
| P1433 | published in | Preventive Veterinary Medicine | Q15761719 |
| P1476 | title | Factors affecting the cost-effectiveness of on-farm culture prior to the treatment of clinical mastitis in dairy cows | |
| P478 | volume | 145 |
Search more.